Fig. 5From: Enhancement of scutellarin oral delivery efficacy by vitamin B12-modified amphiphilic chitosan derivatives to treat type II diabetes induced-retinopathyPharmacokinetics study in vivo. Plasma concentration–time curve of scutellarin after a single oral dose of Scutellarin, Chit-DC-Scu, or Chit-DC-VB12-Scu (at the same scutellarin dose of 40 mg/kg) in rats (n = 6)Back to article page